PET/CT, SPECT/CT beneficial in detecting women's cardiac disease

04/3/2008 | Molecular Imaging Insight

PET/CT and SPECT/CT availability and capabilities present "a real opportunity for improvement in diagnosis and treatment of women's cardiac disease," this article says. Developments in these two imaging technologies are especially important for women, as they are more likely to be underdiagnosed for cardiac disease than men, one expert noted.

View Full Article in:

Molecular Imaging Insight

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park